1.8900
13-2月-25 10:35:36
15 分の遅延
株式
0.0000
0.00%
本日の幅
1.8900 - 1.9600
ISIN
N/A
ソース
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 1 2025 07:00:00 提供 Nasdaq GlobeNewswire